Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.
Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA, Singh S, Mohamed EA, Abu Dabrh AM, Prokop LJ, Wang Z, Murad MH, Mohammed K.
Hepatology. 2016 Jan;63(1):284-306. doi: 10.1002/hep.28280. Epub 2015 Nov 13.
PMID:26566246
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
Choi WM, Kim GA, Choi J, Choi GH, Lee YB, Sinn DH, Lim YS.
Gut. 2024 Mar 7;73(4):649-658. doi: 10.1136/gutjnl-2023-330225.
PMID:37813567
Comparison of viral control between two tenofovir dose reduction regimens (300 mg every 48 hours versus 300 mg every 72 hours) in chronic hepatitis B patients with moderate renal impairment from tenofovir-induced renal dysfunction.
Chotiyaputta W, Poosanasuwansri K, Kiattisunthorn K, Chainuvati S, Tanwandee T.
2018 May 4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
PMID:31643203
Effects of alcohol consumption on viral hepatitis B and C.
Xu HQ, Wang CG, Zhou Q, Gao YH.
World J Clin Cases. 2021 Nov 26;9(33):10052-10063. doi: 10.12998/wjcc.v9.i33.10052.
PMID:34904075
Assessment of Viral and Clinical Characteristics Among Patients With Chronic Hepatitis B Virus Infection in Georgia.
Zakalashvili M, Zarkua J, Metreveli D, Abzianidze T, Butsashvili M, Kamkamidze G.